Quarterly report pursuant to Section 13 or 15(d)

6. Stockholders' Equity (Details Narrative)

v2.4.0.6
6. Stockholders' Equity (Details Narrative) (USD $)
 3 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Apr. 22, 2012
Mar. 31, 2012
Mar. 31, 2011
Stockholders Equity Details Narrative          
Common stock issued to investors     2,360,001    
Issue of Series A Preferred Stock      1,000     
Issue of warrants to purchase common stock     3,471,112    
Common stock issuable upon conversion of the Series A Preferred Stock     1,111,111    
Gross proceeds from the sale of securities $ 3,124,000        
Net proceeds from the sale of securities 2,832,000        
Placement agent commissions 218,680        
Shares to be converted to common stock 1,000        
Beneficial conversion feature 1,062,000        
Warrants initial exercise price $ 1.18        
Warrants exercise term 2 years 6 months        
Black-Scholes fair value of the warrants 2,347,000        
Adjustment of the derivative liability to the current fair value 1,155,000        
Gain due to change in fair value of derivative instruments 1,247,000        
Issue of common stock in connection with the Advocos agreement 74,647 25,000      
Selling, general and administrative expense related to Advocos agreement $ 92,000 $ 47,000      
Adjusted exercise price of warrants $ 3.76        
Issue of additional warrants 73,059        
Total August 13, 2007 warrants outstanding 835,935       762,876